| Pathway ID | hsa05323 |
| Pathway Term | Rheumatoid arthritis |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ANGPT1 | angiopoietin 1 |
284 | Q15389 | chr8: 107,249,482-107,498,055 |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 |
535 | Q93050 | chr17: 42,458,844-42,522,611 |
ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
9114 | P61421 | chr16: 67,438,014-67,481,237 |
ATP6V0E1 | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
8992 | O15342 | chr5: 172,983,757-173,035,445 |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
526 | P21281 | chr8: 20,197,367-20,226,819 |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 |
528 | P21283 | chr8: 103,021,063-103,073,051 |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 |
245973 | Q8NEY4 | chr2: 10,721,649-10,785,110 |
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
51382 | Q9Y5K8 | chr14: 67,294,371-67,360,265 |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F |
9296 | Q16864 | chr7: 128,862,826-128,865,844 |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
9550 | O75348 | chr9: 114,587,746-114,598,373 |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
534 | O95670 | chr6: 31,544,462-31,548,427 |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
51606 | Q9UI12 | chr8: 53,715,557-53,843,558 |
CCL2 | chemokine (C-C motif) ligand 2 |
6347 | P13500 | chr17: 34,255,218-34,257,203 |
CCL20 | chemokine (C-C motif) ligand 20 |
6364 | P78556 | chr2: 227,813,842-227,817,564 |
CCL3 | chemokine (C-C motif) ligand 3 |
6348 | P10147 | chr17: 36,088,256-36,090,169 |
CCL5 | chemokine (C-C motif) ligand 5 |
6352 | P13501 | chr17: 35,871,491-35,880,793 |
CD28 | CD28 molecule |
940 | P10747 | chr2: 203,706,475-203,738,912 |
CTSK | cathepsin K |
1513 | P43235 | chr1: 150,796,208-150,808,323 |
CTSL | cathepsin L |
1514 | P07711 | chr9: 87,725,519-87,731,393 |
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 | P09341 | chr4: 73,869,393-73,871,242 |
CXCL12 | chemokine (C-X-C motif) ligand 12 |
6387 | P48061 | chr10: 44,370,165-44,386,493 |
CXCL5 | chemokine (C-X-C motif) ligand 5 |
6374 | P42830 | chr4: 73,995,642-73,998,779 |
CXCL6 | chemokine (C-X-C motif) ligand 6 |
6372 | P80162 | chr4: 73,836,497-73,849,064 |
CXCL8 | chemokine (C-X-C motif) ligand 8 |
3576 | P10145 | chr4: 73,740,506-73,743,716 |
FOS | FBJ murine osteosarcoma viral oncogene homolog |
2353 | P01100 | chr14: 75,278,774-75,282,230 |
HLA-DMA | major histocompatibility complex, class II, DM alpha |
3108 | P28067 | chr6: 32,948,613-32,969,094 |
HLA-DMB | major histocompatibility complex, class II, DM beta |
3109 | P28068 | chr6: 32,934,629-32,941,070 |
HLA-DOB | major histocompatibility complex, class II, DO beta |
3112 | P13765 | chr6: 32,812,763-32,817,048 |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
3113 | P20036 | chr6: 33,064,569-33,080,775 |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
3117 | P01909 | chr6: 32,628,179-32,647,062 |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 |
3118 | P01906 | chr6: 32,741,342-32,747,215 |
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
3119 | P01920 | chr6: 32,659,467-32,668,383 |
HLA-DRA | major histocompatibility complex, class II, DR alpha |
3122 | P01903 | chr6: 32,439,842-32,445,046 |
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
3123 | P04229 | chr6: 32,578,769-32,589,848 |
HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 |
3125 | P79483 | chr6: 32,444,128-32,457,245 |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
3126 | P13762 | chr6: 32,542,598-32,557,561 |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
3127 | Q30154 | chr6: 32,517,343-32,530,287 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
IL11 | interleukin 11 |
3589 | P20809 | chr19: 55,364,389-55,370,463 |
IL18 | interleukin 18 |
3606 | Q14116 | chr11: 112,143,251-112,164,117 |
IL1A | interleukin 1 alpha |
3552 | P01583 | chr2: 112,773,915-112,784,590 |
IL1B | interleukin 1 beta |
3553 | P01584 | chr2: 112,829,751-112,836,903 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
ITGB2 | integrin subunit beta 2 |
3689 | P05107 | chr21: 44,885,953-44,931,989 |
JUN | jun proto-oncogene |
3725 | P05412 | chr1: 58,780,788-58,784,327 |
MMP1 | matrix metallopeptidase 1 |
4312 | P03956 | chr11: 102,789,920-102,798,160 |
TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
10312 | Q13488 | chr11: 68,039,016-68,050,895 |
TEK | TEK tyrosine kinase, endothelial |
7010 | Q02763 | chr9: 27,109,141-27,230,175 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
TLR2 | toll-like receptor 2 |
7097 | O60603 | chr4: 153,701,500-153,705,699 |
TLR4 | toll-like receptor 4 |
7099 | O00206 | chr9: 117,704,332-117,716,871 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF11A | tumor necrosis factor receptor superfamily member 11a |
8792 | Q9Y6Q6 | chr18: 62,325,287-62,391,292 |
TNFSF11 | tumor necrosis factor superfamily member 11 |
8600 | O14788 | chr13: 42,562,736-42,608,013 |
TNFSF13 | tumor necrosis factor superfamily member 13 |
8741 | O75888 | chr17: 7,558,292-7,561,608 |
TNFSF13B | tumor necrosis factor superfamily member 13b |
10673 | Q9Y275 | chr13: 108,251,240-108,308,484 |
VEGFA | vascular endothelial growth factor A |
7422 | P15692 | chr6: 43,770,184-43,786,487 |